Real-world efficacy and safety of CDK4/6 inhibitors plus endocrine therapy in HR+/HER2 - metastatic breast cancer: a single-institution experience.

J Egypt Natl Canc Inst · 2026 · PMC13415414 · PMID 42521925

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

Patients treated with abemaciclib or with concurrent ovarian suppression showed a numerical trend toward longer survival, in line with results reported in prior studies [ 7 , 8 , 15 , 16 ].

also in 723 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.